SHL Telemedicine (SHLT) Stock Analysis

What SHL Telemedicine does

SHL Telemedicine Ltd., operating with its subsidiaries, specializes in the development and distribution of individualized telehealth services and medical devices. Their reach extends across Israel, Europe, and various international territories. The company's offerings include a suite of personal 12-lead ECG devices: the Smartheart, a mobile unit designed for the early detection of heart attacks; the CardioSen'C, a personal cellular-digital transmitter; the portable Cardio'B; and the handheld Cardio Beeper 12/12, which is capable of transmitting a complete ECG reading to a centralized monitoring facility. Beyond cardiac diagnostics, SHL Telemedicine provides a variety of other remote health monitoring technologies. These encompass a central communication module, a telecommunication device that relays medical data from diverse monitoring instruments to their telemedicine centers; TeleWeight, a trans-telephonic system for personal weight management; TelePress, a remote blood pressure monitoring device for home use; TeleBreather, an electronic handheld instrument for assessing lung function; and the TelePulse Oximeter, an electronic handheld diagnostic tool for measuring blood oxygen saturation levels and pulse rate. These telemedicine solutions and devices are delivered to subscribers utilizing both telephonic and internet communication channels. The company caters to a wide array of clients, including individual patients, health insurance providers, hospitals, clinics, physicians, and other healthcare organizations. SHL Telemedicine is actively involved in strategic alliances. One such partnership with the Mayo Clinic focuses on evaluating the frequency of emergency department visits, re-hospitalizations, and significant adverse cardiovascular events over a 90-day period following a patient's initial heart attack hospitalization, specifically for those using the FDA-approved SmartHeart 12-lead ECG. Furthermore, a collaboration with the Hebrew University of Jerusalem and the Hadassah Medical Center is dedicated to creating an artificial intelligence tool aimed at predicting future life-threatening cardiac events based on 12-lead ECG monitoring. Established in 1987, SHL Telemedicine Ltd. is headquartered in Tel Aviv, Israel.

Key metrics

ETFs linked to SHLT

Broad-market and Healthcare sector ETFs an investor holding SHL Telemedicine is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SHLT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for SHL Telemedicine?

SHL Telemedicine trades under the ticker SHLT on NASDAQ.

Which exchange is SHLT listed on?

SHLT is listed on NASDAQ.

What sector does SHL Telemedicine operate in?

SHL Telemedicine is classified in the Healthcare sector (Medical - Healthcare Information Services industry).

How can PortView help analyze SHLT in a portfolio?

PortView shows SHLT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.